https://www.nasdaq.com/press-release/assembly-biosciences-outlines-anticipated-2022-pipeline-development-milestones-2022
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10
https://www.nasdaq.com/press-release/assembly-biosciences-presents-new-data-at-aasld-the-liver-meetingtm-highlighting-the
https://www.nasdaq.com/press-release/assembly-biosciences-reports-third-quarter-2021-financial-results-and-recent
https://www.nasdaq.com/press-release/assembly-biosciences-abstracts-selected-for-presentation-at-the-upcoming-aasld-the
https://www.nasdaq.com/press-release/antios-therapeutics-and-assembly-biosciences-announce-clinical-collaboration-0
https://www.nasdaq.com/press-release/antios-therapeutics-and-assembly-biosciences-announce-clinical-collaboration
https://www.nasdaq.com/press-release/assembly-bio-announces-october-conference-participation-2021-10-06
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9
https://www.nasdaq.com/press-release/assembly-bio-announces-decision-to-discontinue-clinical-development-of-abi-h2158-2021
https://www.nasdaq.com/press-release/assembly-bio-selects-fourth-hbv-core-inhibitor-candidate-for-advancement-into
https://www.nasdaq.com/press-release/assembly-biosciences-reports-second-quarter-2021-financial-results-and-recent
https://www.nasdaq.com/press-release/assembly-bio-announces-key-promotions-to-leadership-team-2021-08-03
https://www.nasdaq.com/press-release/nobel-laureate-dr.-michael-houghton-appointed-to-assembly-biosciences-board-of
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8
https://www.nasdaq.com/press-release/assembly-biosciences-presents-data-from-hbv-core-inhibitor-programs-at-the
https://www.nasdaq.com/press-release/assembly-biosciences-to-present-data-from-hbv-core-inhibitor-programs-at-the
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7
https://www.nasdaq.com/press-release/dr.-lisa-johnson-pratt-joins-assembly-biosciences-board-of-directors-2021-05-24
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6
https://www.nasdaq.com/press-release/assembly-biosciences-reports-first-quarter-2021-financial-results-and-recent-updates
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5
https://www.nasdaq.com/press-release/assembly-biosciences-and-arbutus-biopharma-initiate-phase-2-clinical-trial-of-triple
https://www.nasdaq.com/press-release/assembly-biosciences-reports-fourth-quarter-and-year-end-2020-financial-results-and
https://www.nasdaq.com/press-release/assembly-biosciences-updates-pipeline-strategy-focusing-on-finite-and-curative
https://www.nasdaq.com/press-release/assembly-bio-announces-upcoming-investor-events-2021-02-19
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021
https://www.nasdaq.com/press-release/assembly-biosciences-to-wind-down-microbiome-program-2020-12-08
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4
https://www.nasdaq.com/press-release/assembly-biosciences-appoints-nicole-s.-white-phd-as-senior-vice-president-of
https://www.nasdaq.com/press-release/assembly-biosciences-and-door-pharmaceuticals-sign-collaboration-and-option-agreement
https://www.nasdaq.com/press-release/assembly-biosciences-presents-data-from-hbv-core-inhibitor-programs-in-poster
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-2020-1
https://www.nasdaq.com/press-release/assembly-biosciences-reports-third-quarter-2020-financial-results-and-business-update
https://www.nasdaq.com/press-release/assembly-biosciences-provides-update-on-the-ongoing-phase-2-extension-study-of
https://www.nasdaq.com/press-release/multiple-abstracts-highlighting-assembly-biosciences-hepatitis-b-core-inhibitor
https://www.nasdaq.com/press-release/assembly-biosciences-appoints-gina-consylman-to-board-of-directors-2020-10-20
https://www.nasdaq.com/press-release/assembly-biosciences-ceo-dr.-john-mchutchison-named-recipient-of-the-prestigious
https://www.nasdaq.com/press-release/assembly-biosciences-announces-october-conference-participation-2020-10-05
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2
https://www.nasdaq.com/press-release/clinical-data-from-assembly-biosciences-hbv-core-inhibitors-presented-at-the-digital
https://www.nasdaq.com/press-release/assembly-biosciences-and-arbutus-biopharma-announce-clinical-collaboration-agreement
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-1
https://www.nasdaq.com/press-release/assembly-biosciences-reports-second-quarter-2020-financial-results-and-recent
https://www.nasdaq.com/press-release/assembly-biosciences-and-beigene-announce-license-and-collaboration-agreement-in
https://www.nasdaq.com/press-release/assembly-biosciences-announces-fda-fast-track-designation-granted-to-abi-h2158-for
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-0
https://www.nasdaq.com/press-release/assembly-biosciences-initiates-phase-2-trial-evaluating-second-generation-core
https://www.nasdaq.com/press-release/preclinical-data-from-assembly-biosciences-immuno-oncology-microbiome-program
https://www.nasdaq.com/press-release/assembly-biosciences-regains-worldwide-rights-to-microbiome-gastrointestinal
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2020
https://www.nasdaq.com/press-release/assembly-biosciences-announces-management-transition-2020-05-27
https://www.nasdaq.com/press-release/assembly-biosciences-to-present-during-the-jefferies-virtual-healthcare-conference
https://www.nasdaq.com/press-release/assembly-biosciences-announces-move-to-virtual-only-annual-meeting-of-stockholders-on
https://www.nasdaq.com/press-release/assembly-biosciences-reports-updates-on-corporate-progress-and-first-quarter-2020
https://www.nasdaq.com/press-release/preclinical-data-from-assembly-biosciences-microbiome-program-in-ulcerative-colitis
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-2020-0
https://www.nasdaq.com/press-release/assembly-biosciences-to-host-conference-call-and-webcast-to-review-hbv-portfolio
https://www.nasdaq.com/press-release/research-by-assembly-biosciences-and-academic-collaborators-published-in-hepatology
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-2020
https://www.nasdaq.com/press-release/assembly-biosciences-appoints-jason-okazaki-as-chief-legal-and-business-officer-2020
https://www.nasdaq.com/press-release/assembly-biosciences-reports-fourth-quarter-and-year-end-2019-financial-results-2020
https://www.nasdaq.com/press-release/assembly-biosciences-to-present-at-the-9th-annual-svb-leerink-global-healthcare
https://www.nasdaq.com/press-release/assembly-biosciences-announces-the-closing-of-its-public-offering-of-common-stock-and
https://www.nasdaq.com/press-release/assembly-biosciences-announces-pricing-of-%24125-million-public-offering-2019-12-12
https://www.nasdaq.com/press-release/assembly-biosciences-announces-proposed-public-offering-of-common-stock-2019-12-11
https://www.nasdaq.com/press-release/assembly-biosciences-announces-plenary-lecture-at-hep-dart-2019-2019-12-06
https://www.nasdaq.com/press-release/assembly-biosciences-announces-presentation-at-jefferies-london-healthcare-conference
https://www.nasdaq.com/press-release/data-for-assembly-biosciences-first-and-second-generation-hbv-core-inhibitors-in
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-2019-0
https://www.nasdaq.com/press-release/assembly-biosciences-reports-third-quarter-2019-financial-results-and-recent
https://www.nasdaq.com/press-release/assembly-biosciences-appoints-luisa-stamm-md-phd-as-chief-medical-officer-2019-11-07
https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-2019
https://www.nasdaq.com/press-release/assembly-biosciences-appoints-thomas-j.-russo-as-chief-financial-officer-2019-10-28
https://www.nasdaq.com/press-release/safety-and-antiviral-activity-of-assembly-biosciences-first-and-second-generation
